{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:00:23Z","timestamp":1760522423022},"reference-count":19,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Context and Objective: Insulin resistance is a central feature of type 2 diabetes. Salicylates prevent lipid-induced insulin resistance in rodents by interrupting inflammatory pathways. We therefore investigated whether salicylates reduce lipid-induced insulin resistance in humans by affecting inflammatory pathways as reflected by serum adipocytokines.<\/jats:p>\n               <jats:p>Participants and Intervention: Ten healthy men were included in a crossover intervention study. Four euglycemic-hyperinsulinemic clamps were performed, one without pretreatment, one with prior 2-h lipid infusion, one after pretreatment with 4 g acetylsalicylic acid (ASA), and one with ASA pretreatment and prior lipid infusion.<\/jats:p>\n               <jats:p>Main Outcome Measure: Lipid-induced insulin resistance was quantified by the euglycemic-hyperinsulinemic clamp technique running at least 2 h. Repeated-measures ANOVA on two factors was used for comparison, and results were Bonferroni adjusted for multiple measurements. ASA effects on serum adipocytokines were addressed by comparing the areas under the curves.<\/jats:p>\n               <jats:p>Results: Glucose infusion rate (M value) of the control clamp without pretreatment was 6.3 (\u00b1 0.6) mg\/kg\u00b7min. ASA pretreatment did not change glucose infusion rates (P = 0.6). Lipid infusion significantly decreased the M value to 4.1 (\u00b1 0.6) mg\/kg\u00b7min (P = 0.008). After ASA pretreatment and lipid infusion, the M value was 4.8 (\u00b1 0.7) mg\/kg\u00b7min and was significantly improved, compared with the lipid-only clamp (P = 0.036 after Bonferroni\u2019s adjustment). General biomarkers of inflammatory processes (IL-6, C-reactive protein), the insulin-sensitizing mediator adiponectin, and circulating adiponectin oligomers were unchanged by ASA pretreatment.<\/jats:p>\n               <jats:p>Conclusions: ASA pretreatment attenuated lipid-induced insulin resistance in healthy humans. This acute insulin-sensitizing effect of ASA was unrelated to changes of circulating inflammatory markers.<\/jats:p>","DOI":"10.1210\/jc.2005-1889","type":"journal-article","created":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T00:23:33Z","timestamp":1139271813000},"page":"964-967","source":"Crossref","is-referenced-by-count":31,"title":["Acetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men"],"prefix":"10.1210","volume":"91","author":[{"given":"Matthias","family":"Mo\u0308hlig","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madlen","family":"Freudenberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bobbert","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ristow","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Rochlitz","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin O.","family":"Weickert","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas F. H.","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Spranger","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, 14558 Nuthetal, Germany; and Department of Endocrinology, Diabetes, and Nutrition, Charite\u0301-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071616144448500_R1","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diabetes.50.7.1612","article-title":"Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects.","volume":"50","author":"Boden","year":"2001","journal-title":"Diabetes"},{"key":"2020071616144448500_R2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I\u03baB-\u03b1.","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"2020071616144448500_R3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk\u03b2.","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"2020071616144448500_R4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1172\/JCI200418712","article-title":"Conditional disruption of I\u03baB kinase 2 fails to prevent obesity-induced insulin resistance.","volume":"113","author":"Ro\u0308hl","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071616144448500_R5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate.","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071616144448500_R6","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.2337\/diabetes.54.9.2712","article-title":"Changes of adiponectin oligomer composition by moderate weight reduction.","volume":"54","author":"Bobbert","year":"2005","journal-title":"Diabetes"},{"key":"2020071616144448500_R7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-\u03baB signaling through a cAMP-dependent pathway.","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"2020071616144448500_R8","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"key":"2020071616144448500_R9","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/clinchem\/43.11.2199","article-title":"Serum concentrations of interleukin-6 are increased when sampled through an indwelling venous catheter.","volume":"43","author":"Gudmundsson","year":"1997","journal-title":"Clin Chem"},{"key":"2020071616144448500_R10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4158\/EP.7.1.44","article-title":"Free fatty acids-the link between obesity and insulin resistance.","volume":"7","author":"Boden","year":"2001","journal-title":"Endocr Pract"},{"key":"2020071616144448500_R11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"2020071616144448500_R12","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jcem.87.5.8450","article-title":"Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.","volume":"87","author":"Bastard","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071616144448500_R13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diabetes.50.5.1126","article-title":"Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.","volume":"50","author":"Hotta","year":"2001","journal-title":"Diabetes"},{"key":"2020071616144448500_R14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1074\/jbc.M205565200","article-title":"Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor \u03b1 (TNF\u03b1)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells.","volume":"278","author":"Jiang","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071616144448500_R15","doi-asserted-by":"crossref","first-page":"24944","DOI":"10.1074\/jbc.M300423200","article-title":"Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases.","volume":"278","author":"Gao","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071616144448500_R16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.","volume":"109","author":"Hundal","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071616144448500_R17","first-page":"279","article-title":"Influence of acetylsalicylic acid on glucose turnover in normal man.","volume":"8","author":"Giugliano","year":"1982","journal-title":"Diabet Metab"},{"key":"2020071616144448500_R18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00291974","article-title":"Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic men.","volume":"28","author":"Bratusch-Marrain","year":"1985","journal-title":"Diabetologia"},{"key":"2020071616144448500_R19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jcem-57-6-1102","article-title":"Aspirin causes tissue insensitivity to insulin in normal man.","volume":"57","author":"Newman","year":"1983","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/3\/964\/10779867\/jcem0964.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/3\/964\/10779867\/jcem0964.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:12:12Z","timestamp":1594955532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/3\/964\/2843444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2005-1889","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}